PCVX icon

Vaxcyte
PCVX

Overview Fund Activity

320 hedge funds and large institutions have $11.5B invested in Vaxcyte in 2024 Q4 according to their latest regulatory filings, with 62 funds opening new positions, 138 increasing their positions, 88 reducing their positions, and 62 closing their positions.

Holders
320
Holders Change
-5
Holders Change %
-1.54%
% of All Funds
4.26%
Holding in Top 10
12
Holding in Top 10 Change
-11
Holding in Top 10 Change %
-47.83%
% of All Funds
0.16%
New
62
Increased
138
Reduced
88
Closed
62
Calls
$48.1M
Puts
$25.7M
Net Calls
+$22.4M
Net Calls Change
-$6.81M

Top Buyers

1
Goldman Sachs
1
Goldman Sachs
New York
$256M
2
Capital Research Global Investors
2
Capital Research Global Investors
California
$508M
3
KCM
3
Kynam Capital Management
New Jersey
$191M
4
State Street
4
State Street
Massachusetts
$372M
5
Westfield Capital Management
5
Westfield Capital Management
Massachusetts
$210M

Top Sellers

1
DGM
1
Darwin Global Management
Jersey
$0
2
Fidelity Investments
2
Fidelity Investments
Massachusetts
$1.07B
3
T. Rowe Price Investment Management
3
T. Rowe Price Investment Management
Maryland
$234M
4
FAM
4
Fred Alger Management
New York
$42.8M
5
CAM
5
Cormorant Asset Management
Massachusetts
$34.8M
Name Holding Trade Value Shares
Change 		Shares
Change %
DCM
26
Driehaus Capital Management
Illinois
$95.5M -$45.4M -554,463 -32%
Invesco
27
Invesco
Georgia
$95.5M -$12M -146,042 -11%
Northern Trust
28
Northern Trust
Illinois
$95M +$10.1M +123,584 +12%
WP
29
Woodline Partners
California
$91.8M +$1.39M +16,977 +2%
ClearBridge Investments
30
ClearBridge Investments
New York
$90.2M -$4.65M -56,794 -5%
Norges Bank
31
Norges Bank
Norway
$90.1M +$90.1M +1,100,286 New
Pictet Asset Management
32
Pictet Asset Management
Switzerland
$83.3M +$19.4M +236,940 +30%
PCH
33
Polar Capital Holdings
United Kingdom
$79.7M -$1.81M -22,134 -2%
D.E. Shaw & Co
34
D.E. Shaw & Co
New York
$63.5M +$28.8M +352,155 +83%
NHAS
35
Novo Holdings A/S
Denmark
$61.4M – – –
UBS Group
36
UBS Group
Switzerland
$60.3M +$51.2M +624,988 +560%
Ameriprise
37
Ameriprise
Minnesota
$58.7M +$30M +366,622 +105%
PBPIA
38
Pivotal bioVenture Partners Investment Advisor
California
$57.6M +$5.26M +64,295 +10%
Morgan Stanley
39
Morgan Stanley
New York
$56.8M -$126K -1,536 -0.2%
American Century Companies
40
American Century Companies
Missouri
$49.5M +$6.24M +76,262 +14%
Allspring Global Investments
41
Allspring Global Investments
North Carolina
$49.4M +$20.5M +246,049 +71%
Ensign Peak Advisors
42
Ensign Peak Advisors
Utah
$48M +$3.22M +39,293 +7%
Brown Advisory
43
Brown Advisory
Maryland
$45.5M +$9.18M +112,170 +25%
FLSM
44
Frazier Life Sciences Management
California
$44.2M -$27.8M -340,000 -39%
Nuveen Asset Management
45
Nuveen Asset Management
Illinois
$43.4M +$5.38M +65,713 +14%
FAM
46
Fred Alger Management
New York
$42.8M -$59M -720,710 -58%
Lazard Asset Management
47
Lazard Asset Management
New York
$39.8M +$39.8M +486,764 New
UBS AM
48
UBS AM
Illinois
$38.7M +$5.3M +64,690 +16%
Bank of America
49
Bank of America
North Carolina
$38.5M -$8.18M -99,979 -18%
CAM
50
Cormorant Asset Management
Massachusetts
$34.8M -$47.1M -575,000 -58%
1
2
3 4 5